Page 565 - Read Online

Page 12 of 13 Maurina et al. Mini-invasive Surg 2021;5:53 https://dx.doi.org/10.20517/2574-1225.2021.88

management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task
Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019;74:104-32. DOI PubMed
12. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion -
an update. EuroIntervention 2020;15:1133-80. DOI PubMed
13. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of
stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42. DOI PubMed
14. Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in
patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014;64:1-12. DOI PubMed
15. Lakkireddy D, Thaler D, Ellis CR, et al; Amulet IDE Investigators. Amplatzer™ Amulet™ left atrial appendage occluder versus
watchman™ device for stroke prophylaxis (Amulet IDE): a randomized controlled trial. Circulation 2021. DOI PubMed
16. Reddy VY, Doshi SK, Kar S, et al; PREVAIL and PROTECT AF Investigators. 5-year outcomes after left atrial appendage closure:
from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 2017;70:2964-75. DOI PubMed
17. Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a
contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with Watchman left atrial appendage closure
technology). J Am Coll Cardiol 2013;61:2551-6. DOI PubMed
18. Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience
with the AMPLATZER Cardiac Plug. EuroIntervention 2016;11:1170-9. DOI PubMed
19. Hildick-Smith D, Landmesser U, Camm AJ, et al. Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results
of the prospective global observational study. Eur Heart J 2020;41:2894-901. DOI PubMed PMC
20. Huang H, Liu Y, Xu Y, et al. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial
fibrillation: a prospective, multicenter clinical study. JACC Cardiovasc Interv 2017;10:2188-94. DOI PubMed
21. Pagnotta PA, Chiarito M, Pllaha E, et al. Left atrial appendage closure with the Ultraseal device: initial experience and mid-term
follow-up. J Interv Cardiol 2018;31:932-8. DOI PubMed
22. Sabiniewicz R, Hiczkiewicz J, Wańczura P, Stecko W, Curzytek A. First-in-human experience with the Cardia Ultraseal left atrial
appendage closure device: the feasibility study. Cardiol J 2016;23:652-4. DOI PubMed
23. Briosa E Gala A, Pope MTB, Monteiro C, et al. Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial
appendage closure in a United Kingdom tertiary center: an 11-year experience. Heart Rhythm 2021;18:1724-32. DOI PubMed
24. Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial
fibrillation: initial clinical experience. J Am Coll Cardiol 2013;62:108-18. DOI PubMed
25. Miller MA, Gangireddy SR, Doshi SK, et al. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial
appendage closure using an epicardial suture snaring device. Heart Rhythm 2014;11:1853-9. DOI PubMed
26. Price MJ, Gibson DN, Yakubov SJ, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from
the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol 2014;64:565-72. DOI PubMed PMC
27. Vos LM, Kotecha D, Geuzebroek GSC, et al. Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis.
Europace 2018;20:1790-7. DOI PubMed PMC
28. Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing
catheter ablation: BELIEF trial. J Am Coll Cardiol 2016;68:1929-40. DOI PubMed
29. Caliskan E, Sahin A, Yilmaz M, et al. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients
with atrial fibrillation undergoing cardiac surgery. Europace 2018;20:e105-14. DOI PubMed
30. Whitlock RP, Belley-Cote EP, Paparella D, et al; LAAOS III Investigators. Left atrial appendage occlusion during cardiac surgery to
prevent stroke. N Engl J Med 2021;384:2081-91. DOI PubMed
31. Handke M, Harloff A, Hetzel A, Olschewski M, Bode C, Geibel A. Left atrial appendage flow velocity as a quantitative surrogate
parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a
transesophageal echocardiographic study in 500 patients with cerebral ischemia. J Am Soc Echocardiogr 2005;18:1366-72. DOI
PubMed
32. Wang DD, Eng M, Kupsky D, et al. Application of 3-dimensional computed tomographic image guidance to WATCHMAN
implantation and impact on early operator learning curve: single-center experience. JACC Cardiovasc Interv 2016;9:2329-40. DOI
PubMed
33. Goitein O, Fink N, Hay I, et al. Cardiac CT angiography (CCTA) predicts left atrial appendage occluder device size and procedure
outcome. Int J Cardiovasc Imaging 2017;33:739-47. DOI PubMed
34. Mo BF, Wan Y, Alimu A, et al. Image fusion of integrating fluoroscopy into 3D computed tomography in guidance of left atrial
appendage closure. Eur Heart J Cardiovasc Imaging 2021;22:92-101. DOI PubMed
35. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman
Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access
Registry. Circulation 2011;123:417-24. DOI PubMed
36. Landmesser U, Tondo C, Camm J, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up
from the prospective global Amulet observational registry. EuroIntervention 2018;14:e590-7. DOI PubMed
37. Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization, and clinical impact of device-related thrombus following left
atrial appendage occlusion in the prospective global AMPLATZER Amulet observational study. JACC Cardiovasc Interv
2019;12:1003-14. DOI PubMed
38. Simard T, Jung RG, Lehenbauer K, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion.